Catalyst
Slingshot members are tracking this event:
Initial Phase 1 clinical data for ALN-GO1 in treating Primary Hyperoxaluria Type 1 will be presented in late 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALNY | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 24, 2016
Occurred Source:
http://investors.alnylam.com/releasedetail.cfm?ReleaseID=990764
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Initial Phase 1 Clinical Data, Aln-go1, Primary Hyperoxaluria Type 1
